$39.14
-0.25-0.63%
At close: -
$39.14
0.000.00%
After Hours: 4:01 PM EDT
Amphastar Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amphastar Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $0.96 | $0.99 | -3.03 % |
Jun 2024 | 2024-08-07 | $0.94 | $0.77 | 22.1 % |
Mar 2024 | 2024-05-08 | $1.04 | $0.74 | 40.5 % |
Dec 2023 | 2024-02-28 | $0.88 | $0.91 | -3.30 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $191.21M | $194.69M | -1.79 % |
Jun 2024 | 2024-08-07 | $182.39M | $170.94M | 6.70 % |
Mar 2024 | 2024-05-08 | $171.84M | $174.90M | -1.75 % |
Dec 2023 | 2024-02-28 | $178.11M | $175.67M | 1.39 % |
Amphastar Pharma (AMPH) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $0.96, which missed the estimate of $0.99.
The Actual Revenue was $191.2M, which missed the estimate of $194.7M.
Browse earnings estimates, EPS, and revenue on all stocks.